SOX18 is a transcriptional activator that binds the consensus sequence 5'-AACAAAG-3' and plays essential roles in embryonic cardiovascular development and lymphangiogenesis by activating PROX1 and lymphatic endothelial markers 1. During postnatal angiogenesis, SOX18 functions with functional redundancy to SOX17 2. SOX18 is required for normal hair development, with Hedgehog signaling upregulating SOX18 in dermal papilla fibroblasts to promote hair growth through SCUBE3/TGF-β mechanisms 3. Beyond developmental roles, SOX18 has significant pathological importance. In hepatocellular carcinoma, TGF-β1 upregulates SOX18 via Smad2/3 activation, and SOX18 transactivates PD-L1 and CXCL12 to create immunosuppressive microenvironments promoting tumor progression and metastasis 1. SOX18 is upregulated in multiple cancer types and associated with poor prognosis 2. In infantile hemangioma, propranolol inhibits pathological vasculogenesis by suppressing SOX18-mediated mevalonate pathway signaling, suggesting statins as potential therapeutics 4. Conversely, in abdominal aortic aneurysm, SOX18 downregulation promotes endothelial-to-mesenchymal transition; EC-specific SOX18 overexpression inhibits this transition and attenuates aneurysm formation 5. SOX18 is also modulated in glioma progression through enhancer-SNP-MEIS1 interactions 6.